A crisis foretold
http://www.eluniversal.com/nacional-y-politica/160305/a-crisis-foretold
Dramatic testimonies of sick people queuing at public and private pharmacies tell of the tragedy that the population is experiencing due to the shortages of medicines now ravaging Venezuela. A person who is forced to stand in a queue for unavailable drugs is the last link in a chain of causes which begins in the lack of prevention, followed by the lack of medical care due to lack of medical supplies and, finally, lack of medication. The Venezuelan Pharmaceutical Federation (Fefarven), which represents the pharmaceutical sector, estimates that as much as 80% of all medicines are in short supply or unavailable. Three years ago, the pharmaceutical sector declared an emergency when the shortage reached 15%, while suppliers of medical and surgical equipment declared themselves in technical closure.
Various health unions, drugmakers and distributors associations, medical and scientific organizations, the opposition-controlled National Assembly, the Medical College of Physicians, and health advocacy doctors have called this a "humanitarian crisis".
Doctors like José Félix Oletta, Rafael Orihuela, Harry Acquatella, and María Yanes, along with deputy and Doctor José Manuel Olivares, have called on the Government to recognize the health emergency. "A humanitarian crisis is an emergency situation in a country that threatens the life and health of the population," said Dr. María Yanes. Deputy José Manuel Olivares said that everything is ready for the World Health Organization (WHO) to coordinate international aid in order to supply treatment medications and medical supplies, but application for aid must be submitted by the government, and so far the ruling party's deputies have dismissed this move.
-------------
However, the president did not specify how the production in the country will be boosted or how to address the factors involved in insufficient pharmaceutical manufacturing capacities. A total of 143 manufacturing laboratories used to produce medicines in the country at full capacity, but today only some 40 have productive capacity, the rest is below 50% of installed capacity or have had to close operations, as reported by Eyerforpharma A. L., a company that analyzes information concerning the pharmaceutical industry in the region.